Previous 10 | Next 10 |
janiecbros/E+ via Getty Images Biotech M&A is poised to heat up again as shares of the SPDR S&P Biotech’s (XBI) have fallen about 25% from their February highs, according to Jefferies. Biotech deals may pick up after a 3-6 month of a large "drawdown" and as prices "normalize" f...
Pacira BioSciences (PCRX) has entered into a distribution agreement with Eurofarma Laboratories for the development and commercialization of EXPAREL (bupivacaine liposome injectable suspension) in Latin America.Under the terms of the agreement, Eurofarma obtains the exclusive right ...
PARSIPPANY, N.J., June 22, 2021 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to non-opioid pain management and regenerative health solutions, today announced that it has entered into a distribution agreement with Eurofarma Laboratories S...
Pacira BioSciences ([[PCRX]] -1.9%) has announced a $41.2M and $1M preliminary net product sales in May for EXPAREL (bupivacaine liposome injectable suspension) and iovera, respectively.EXPAREL average daily sales for the month of May 2021 were 162% of May 2020 and 105% of April 202...
-- EXPAREL average daily sales for May 2021 were 162% of May 2020 -- -- EXPAREL momentum continues with average daily sales for May 2021 at 105% of April 2021 -- PARSIPPANY, N.J., June 08, 2021 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its...
Pacira BioSciences (PCRX) announces topline results from its Phase 3 STRIDE study evaluating Exparel in 120 subjects undergoing lower extremity surgeries.Exparel administered as combined sciatic (in popliteal fossa) and saphenous (in adductor canal) nerve blocks did not demonstrate statistica...
-- Study did not demonstrate statistical significance for primary endpoint of pain reduction from 0 to 96 hours for EXPAREL versus bupivacaine HCl -- -- EXPAREL achieves highly statistically significant reductions in pain and total opioid consumption from 24 to 96 hours versus bup...
John Paulson’s 13F portfolio value increased from $3.85B to $4.35B this quarter. Paulson & Company added Perpetua Resources and increased Alexion Pharmaceuticals while dropping Discovery and ViacomCBS during the quarter. Their top three positions are at 45% of the entir...
PARSIPPANY, N.J., May 25, 2021 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX) today announced that it will present at the 2021 Jefferies Virtual Healthcare Conference at 9:30 AM ET on Tuesday, June 1, 2021. Live audio of the virtual event can be accessed by visiting the ...
Heron finally received FDA approval for Zynrelef but it came with a surprisingly narrow label. The company believes it can secure a broad label with additional studies but the narrow label will likely impact Zynrelef's growth trajectory. The CINV franchise is expected to start to ...
News, Short Squeeze, Breakout and More Instantly...
Pacira BioSciences Inc. Company Name:
PCRX Stock Symbol:
NASDAQ Market:
Pacira BioSciences Inc. Website:
TAMPA, Fla., July 23, 2024 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ:PCRX) today announced that it will report its second quarter financial results after the close of the U.S. markets on Tuesday July 30, 2024. Following the release, the company will host a live conference call and webc...
-- Proposed Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment System Rule extends separate payment from ambulatory surgical centers to include the hospital outpatient environment – -- Rule implements the NOPAIN Act, signed into law as part of the Cons...
A look at the top 10 most actives in the United States Ocean Power Technologies Inc. (OPTT) rose 86.1% to $0.514 on volume of 587,366,807 shares NVIDIA Corporation (NVDA) fell 1.3% to $122.67 on volume of 214,038,378 shares Tesla Inc. (TSLA) rose 10.2% to $231.26 on volume of 201,850,947 ...